196 related articles for article (PubMed ID: 7087509)
21. Oxygen-derived free radical scavengers for amelioration of reperfusion damage in heart transplantation.
Jurmann MJ; Schaefers HJ; Dammenhayn L; Haverich A
J Thorac Cardiovasc Surg; 1988 Mar; 95(3):368-77. PubMed ID: 3278168
[TBL] [Abstract][Full Text] [Related]
22. Dichloroacetate enhanced myocardial functional recovery post-ischemia : ATP and NADH recovery.
Wahr JA; Olszanski D; Childs KF; Bolling SF
J Surg Res; 1996 Jun; 63(1):220-4. PubMed ID: 8661201
[TBL] [Abstract][Full Text] [Related]
23. Myocardioprotective effects of the combination of ischemic preconditioning with hypothermia and crystalloid cardioplegia in immature rabbits.
Zhu SS; Zhang ZM; Zhang YC; Xu PC; Dong HY; Fan JW; Zeng YM
Sheng Li Xue Bao; 2004 Jun; 56(3):389-96. PubMed ID: 15224156
[TBL] [Abstract][Full Text] [Related]
24. Role of polymorphonuclear leukocytes in reperfusion injury of globally ischemic rat heart.
Malatiali SA; Juggi JS
Can J Cardiol; 1995 Feb; 11(2):147-58. PubMed ID: 7866939
[TBL] [Abstract][Full Text] [Related]
25. Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists.
Bolling SF; Badhwar V; Schwartz CF; Oeltgen PR; Kilgore K; Su TP
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):476-81. PubMed ID: 11547297
[TBL] [Abstract][Full Text] [Related]
26. Continuous versus intermittent warm blood cardioplegia: functional and energetics changes.
Torracca L; Pasini E; Curello S; Ceconi C; Coletti G; Alfieri O; Solfrini R; Ferrari R
Ann Thorac Surg; 1996 Oct; 62(4):1172-8; discussion 1178-9. PubMed ID: 8823108
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation.
Okada K; Yamashita C; Okada M; Okada M
J Heart Lung Transplant; 1996 May; 15(5):475-84. PubMed ID: 8771503
[TBL] [Abstract][Full Text] [Related]
28. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
[TBL] [Abstract][Full Text] [Related]
29. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia.
Amrani M; Gray CC; Smolenski RT; Goodwin AT; London A; Yacoub MH
Circulation; 1997 Nov; 96(9 Suppl):II-274-9. PubMed ID: 9386110
[TBL] [Abstract][Full Text] [Related]
30. Beta-adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals.
Persad S; Takeda S; Panagia V; Dhalla NS
J Mol Cell Cardiol; 1997 Feb; 29(2):545-58. PubMed ID: 9140814
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of diltiazem and ryanodine against ischemia-reperfusion injury in neonatal rabbit hearts.
Akita T; Abe T; Kato S; Kodama I; Toyama J
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):55-66. PubMed ID: 8321005
[TBL] [Abstract][Full Text] [Related]
32. Effect of calcium and preischemic hypothermia on recovery of myocardial function after cardioplegic ischemia in neonatal lambs.
Aoki M; Nomura F; Kawata H; Mayer JE
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):207-12; discussion 212-3. PubMed ID: 8429646
[TBL] [Abstract][Full Text] [Related]
33. Protection of the neonatal heart following normothermic ischemia: a comparison of oxygenated saline and oxygenated versus nonoxygenated cardioplegia.
Lynch MJ; Bove EL; Zweng TN; Fox MH; Bolling SF; Gallagher KP
Ann Thorac Surg; 1988 Jun; 45(6):650-5. PubMed ID: 3377577
[TBL] [Abstract][Full Text] [Related]
34. Ischemic preconditioning, cardioplegia or both? Differing approaches to myocardial and vascular protection.
Kolocassides KG; Galiñanes M; Hearse DJ
J Mol Cell Cardiol; 1996 Mar; 28(3):623-34. PubMed ID: 9011645
[TBL] [Abstract][Full Text] [Related]
35. Superoxide dismutase and catalase in protection of cardiopulmonary bypass-induced cardiac dysfunction and cellular injury.
Prasad K; Chan WP; Bharadwaj B
Can J Cardiol; 1996 Oct; 12(10):1083-91. PubMed ID: 9191502
[TBL] [Abstract][Full Text] [Related]
36. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
37. Incomplete recovery of working heart function after twenty-four-hour preservation with a modified University of Wisconsin solution.
Smolens IA; Follette DM; Berkoff HA; Castellanos LM; Segel LD
J Heart Lung Transplant; 1995; 14(5):906-15. PubMed ID: 8800727
[TBL] [Abstract][Full Text] [Related]
38. Resistance of neonatal myocardium to injury during normothermic and hypothermic ischemic arrest and reperfusion.
Grice WN; Konishi T; Apstein CS
Circulation; 1987 Nov; 76(5 Pt 2):V150-5. PubMed ID: 3665013
[TBL] [Abstract][Full Text] [Related]
39. Preservation of myocardial function with mannitol reperfusate.
Ouriel K; Ginsburg ME; Patti CS; Pearce FJ; Hicks GL
Circulation; 1985 Sep; 72(3 Pt 2):II254-8. PubMed ID: 3928190
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of surgically induced ischemia/reperfusion injury by oxygen free radical scavengers.
Stewart JR; Blackwell WH; Crute SL; Loughlin V; Greenfield LJ; Hess ML
J Thorac Cardiovasc Surg; 1983 Aug; 86(2):262-72. PubMed ID: 6876862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
